Top Tech Companies in Boston, MA (4,697)

Strong Revenue Growth: Sales are reported to have risen from about $39 billion (2023) to more than $43 billion (2025), with 2024–2025 gains attributed to institutional solutions, whole life, and annuities.

Profitability: Operating earnings are characterized as increasing from $2.8 billion in 2024 to nearly $3.9 billion in 2025, a company‑record level.

Investor Backing & Capital Strength: Capital levels are described as strong, with total adjusted capital at $34.4 billion in 2025 and high financial‑strength ratings maintained across major agencies.

Strong Revenue Growth: Net revenue rose at double‑digit rates in 2025 and continued to increase at a similar pace in early 2026, supported by higher gross dollar volume, cross‑border activity, and switched transactions. The multi‑quarter trend indicates consistent top‑line momentum rather than a one‑off spike.

Profitability: Operating income outpaced revenue growth in 2025, expanding margins, while net income and EPS also advanced strongly. This points to operating leverage as volumes and higher‑yield cross‑border flows scale.

Diversified Revenue Streams: Value‑added services and solutions grew markedly faster than the core network, with security, digital authentication, analytics, and consulting cited as key contributors. This mix shift broadens growth beyond card payment fees and supports resilience.

Strong Revenue Growth: Results show sustained low- to mid‑20s year‑over‑year expansion, including roughly 23% in Q2 2026 and 24% for full‑year 2025. Guidance points to continued double‑digit growth in recurring gross profit.

Profitability: Financial disclosures indicate rising GAAP profitability, with Q2 2026 net income increasing to about $154 million and adjusted EBITDA stepping up alongside raised full‑year targets. Profit growth is occurring in tandem with expanding scale across ARR, locations, and GPV.

Strong Market Position & Advantage: Evidence characterizes the company as a leading U.S. restaurant‑focused platform with approximately 180,000 locations, record quarterly net adds, and notable enterprise wins and partnerships. Scale in locations and GPV reinforces competitive positioning within restaurant technology and payments.

Strong Revenue Growth: UK company filings indicate revenue rose from about £169.4m in 2023 to £197.0m in 2024, evidencing clear double-digit growth. Parent-company reporting in 2025 also attributed an increase in its ‘Other revenues’ to growth in Simply Business.

Profitability: Operating profit reportedly increased from roughly £24.2m to £45.9m in 2024, rising far faster than revenue. This points to improving margins and efficiency alongside scale.

Market Expansion: The business surpassed one million customers globally in 2024 and later reached one million in the UK, with continued activity in the U.S. and new partnerships and office investments. These milestones suggest ongoing expansion of reach and channels.

Investor Backing & Capital Strength: Recent financing includes a $50 million Series D anchored by Boehringer Ingelheim, following a Series C in 2025 and prior debt financing, indicating sustained access to strategic capital. The transfer of CT-155 commercialization responsibility alongside dedicated commercial funding further underscores capital support aligned with near-term growth plans.

Strategic Partnerships: Collaborations with major pharmaceutical companies such as Otsuka and Boehringer Ingelheim, alongside agreements with Indivior and Ultrahuman, reflect deepening partner engagement in development and commercialization. These alliances have produced FDA-authorized products and structured milestone and royalty pathways that reinforce external validation.

Product Line Growth: Multiple FDA authorizations (Rejoyn for MDD and CT-132 for migraine), the acquisition of AspyreRx, and an expanded pipeline spanning psychiatry, neurology, and cardiometabolic disease point to a broader, more mature portfolio. Positive Phase 3 results and commercialization preparations for CT-155 add momentum to this expansion.

Strong Revenue Growth: Recent filings and earnings updates indicate sustained double-digit increases across annual and quarterly revenue, with momentum continuing into 2026. Guidance was raised during the year, reinforcing ongoing top-line expansion across core verticals.

Profitability: Results point to improving earnings quality, including a shift to positive net income on an annual basis and expanding adjusted EBITDA margins. Management also signaled further margin gains in 2026.

Customer Loyalty & Retention: Disclosures highlight a growing client base alongside net dollar-based retention that indicates expansion within existing customers. Wins across education, travel, healthcare, and B2B suggest durable relationships that support recurring growth.

Investor Backing & Capital Strength: Capital raising has accelerated, including a $372M Series D in 2024 with total funding reported in the hundreds of millions to expand the pipeline and AI platform. Valuation has stepped up from roughly $1.04B (2021) to about $1.48B post‑money (2024), signaling strengthened private‑market positioning.

Strategic Partnerships: Partnerships are expanding, highlighted by a collaboration with Sanofi and OpenAI to build AI software for drug development and increased business‑development capacity via Entrepreneurs in Residence. Engagements with large pharma partners, including Sanofi, underscore growing external validation and deal flow.

Product Line Growth: The pipeline is broadening through multiple in‑licenses—such as an anti‑CD226 program, a CNS‑penetrant TYK2 inhibitor, and a miR‑124 activator—and progression to first‑in‑human dosing of BLKR201 in 2026. Stated plans to reach 10–15 assets over 3–5 years align with recent portfolio expansion and clinical advancement.

Strong Revenue Growth: Reported results show revenue rising from $3.67B (2023) to $4.77B (2024) to $6.05B (2025), with early 2026 revenue and guidance pointing to further gains. Q1 2026 continued to grow year over year, alongside expanding sportsbook handle and average monthly payers.

Profitability: Reported results show Adjusted EBITDA improving from $181M (2024) to $620M (2025) and a shift to positive GAAP net income in 2025. Guidance indicates substantial Adjusted EBITDA for 2026.

Product Line Growth: Company disclosures describe rising iGaming revenue in 2025 and the launch of new offerings like Predictions and a consolidated “super app.” These additions broaden the business beyond traditional sportsbook and DFS.

Investor Backing & Capital Strength: Funding progressed from a 2022 seed to a 2023 Series A and a $27M Series B in 2025, led by established firms, indicating strong capital support. Independent listings also note roughly $44M+ raised to date.

Market Expansion: The customer base expanded from 1,000+ paying businesses in 2022 to 6,000+ across all 50 states by 2025–2026, signaling broader penetration. Reported booked business rose from $25M+ (2022) to $655M+ (2025) and $1.2B+ (2026), reflecting sharply higher platform activity.

Product Line Growth: Offerings evolved from AI-generated websites to a broader suite spanning marketing, bookings, payments, CRM/messaging, and an AI 'Sidekick' mobile app. This widening scope is accompanied by continued hiring across sales, product, engineering, and AI/ML to support scale.

Strong Revenue Growth: Revenue is scaling at strong double-digit rates, reaching $702M in FY2026 and continuing to rise in subsequent quarters, with full‑year FY2027 guidance lifted into the low‑$900M range. Multiple updates indicate momentum in both reported results and outlook.

Healthy Cash Flow: Operating cash flow turned positive in FY2026 and free cash flow was also positive, alongside progress in non‑GAAP profitability in later quarters. These milestones suggest improving financial efficiency as scale increases.

Diversified Customer Base: The company reports 12,500+ active customers and continued wins with large enterprises across technology, manufacturing, and healthcare. This breadth points to demand resilience across multiple industries.

Strong Revenue Growth: Revenue grew 26% year over year in FY2024. ARR increased 30% in 2023 after crossing the $100M threshold in 2022.

Profitability: Operations remained profitable and cash‑flow positive in FY2024 while the organization expanded to just under 600 employees.

Investor Backing & Capital Strength: A July 2024 majority investment led by Vista Equity Partners (with TCV and KKR) valued the company at about $1.2B. This reflects substantial external capital support for continued expansion.

Investor Backing & Capital Strength: Capital resources include a $100M social bond, audited net asset growth in 2025, and $118M of impact investments deployed over four years. These signals indicate ample capacity to fund programs and expansion.

Market Expansion: Activities include the 2026 acquisition of Lab4U, scaling of Education at Work, and reported reach of 15M+ young people annually. Continued initiatives and campaigns following the 2026 rebrand point to a widening footprint.

Strategic Partnerships: Collaborations span major field builders and funders, such as the Britebound Center for Career Navigation at JFF and a grantee community of 100+ organizations across 49 states and Puerto Rico. These ties support national presence and program scaling.

Strong Hiring & Retention: Headcount is described as rising from about 134 in 2023 to roughly 176 by March 2026, and job postings increased from 2024 into 2026, pointing to active hiring. This trend indicates added capacity to support continued expansion.

Strategic Partnerships: A global partnership model announced in 2024 brought other freelance marketplaces into the network, signaling deliberate ecosystem expansion. These partnerships support broader geographic reach and customer access.

Strong Market Position & Advantage: The company highlights a substantial enterprise footprint, including a significant share of Fortune 500 companies, reflecting deep penetration at the high end of the market. It was also named the 2nd fastest‑growing company in Massachusetts based on three‑year revenue growth, reinforcing competitive standing.

Resilient & Sustainable Growth: Revenue and ARR continued to rise, with ARR surpassing $300M by 2025 and revenue increasing in 2024. Feedback suggests growth has moderated from earlier hypergrowth into a steadier, efficiency‑focused trajectory while the customer base expanded to 4,500+.

Product Line Growth: Snyk Code reached $100M in ARR and newer offerings such as DAST and AI‑focused products (e.g., Evo) showed strong momentum. These developments indicate the platform is extending beyond its original core into additional security categories.

Market Expansion: Enterprise adoption intensified, with that segment driving a large share of new additions and AI security opening fresh routes to demand. Customer counts grew materially from 2024 into 2025, signaling broader market reach.

Strong Market Position & Advantage: Ekotrope is positioned as the most widely used HERS rating software in the U.S., supporting roughly 1 in 4 new homes and serving 7,000+ builders with 400,000+ homes per year. Penetration spans hundreds of HERS rating companies and more than 40 utility new‑construction programs.

Investor Backing & Capital Strength: An $11M financing in October 2025, bringing tracked cumulative funding to about $15.9M, underscores continued capital support for expansion. Multiple independent profiles indicate the company has raised additional capital over time rather than a single one‑off event.

Product Line Growth: The company has expanded beyond its core RATER tool into Market Intelligence data products and solutions for utilities, builders, manufacturers, and lenders. Release history shows major version updates (e.g., Version 5.0 in 2025 with additional releases in 2026), indicating an active roadmap.

Strong Revenue Growth: Recent results indicate FY2026 revenue rose 19% year over year to roughly $2.02B, with Q1 FY2027 revenue up 16% and ARR up 17%. This points to steady double‑digit expansion across both total and recurring revenue.

Customer Loyalty & Retention: Dollar-based net retention is reported around 110–111%, and ARR growth has tracked slightly ahead of revenue growth. These signals suggest existing customers are expanding usage alongside new logo additions.

Healthy Cash Flow: Company materials highlight strong free cash flow alongside growth, including substantial FY2026 free cash flow and robust margins in recent quarters. The business has also returned capital via notable share repurchases.

Strong Revenue Growth: ARR increased from $177M in 2024 to $218M in 2025, with reported ARR roughly doubling since 2021. Platform activity also expanded as GMV rose from $11.2B to about $14.6–$15B over the same period.

Profitability: The group was profitable throughout 2025, following earlier profitability in the core Platform business. This progression indicates improving operating leverage alongside continued expansion.

Diversified Revenue Streams: Newer products are contributing incremental revenue, with Mirakl Connect generating about $11.7M ARR in under a year and Mirakl Ads seeing a sharp rise in ad spend in 2025. Customer additions (45 global enterprises in 2025) and launches across marketplace and dropship broaden the commercial base.

Strong Hiring & Retention: Hiring and headcount are expanding, with disclosures of 15,000+ global employees, thousands of new hires, and third‑party estimates indicating continued workforce growth. Available evidence also points to active internal mobility and a recent increase in active job postings.

Market Expansion: Geographic and client footprints are broadening, with 40+ offices and 1,700+ customers across 170+ countries alongside concrete investments in new and expanded locations such as Hyderabad and Kingston. These moves indicate scaling delivery capacity in major capability centers and new regions.

Innovation-Driven Growth: The offering mix is shifting toward AI, data, technology, and platforms, including proprietary solutions and product capabilities. Strategic moves such as Salesforce-focused acquisitions and collaborations, plus a Tulip solution partnership, extend capabilities beyond traditional consulting.

Investor Backing & Capital Strength: Funding reached a $200M Series C in July 2024 at a $1B valuation with prominent investors. Available evidence suggests substantial capital to scale and strong external confidence.

Market Expansion: Engagements extended across governments and enterprises, including the UK’s £8M three-year program, a CBP contract expansion, and new deployments with General Atomics Aeronautical Systems and Scarbrough Global; by 2026, the company said 8 of the world’s 10 largest logistics providers were customers. These signals indicate continued penetration into large, international accounts and public-sector programs.

Product Line Growth: The offering broadened beyond supply-chain mapping into compliance, procurement, trade-risk management, and customs-automation workflows, including the 2026 Cervo AI acquisition. 2025–2026 materials describe additional use cases and live customer deployments.

Product Line Growth: Active ETFs are expanding, with MFS entering the U.S. ETF market in late 2024 and generating about $1.2B of net inflows and over $1.4B in AUM by year‑end 2025. The lineup continued to scale in 2026 with additional active ETF launches.

Strong Market Position & Advantage: Scale remains substantial, with AUM around $651.4B at year‑end 2025 and generally in the $640–$660B range through mid‑2026. Company materials also cite a top‑10 standing among U.S. active long‑term mutual fund and ETF managers.

Profitability: Earnings resilience is evident as higher average net assets supported slightly higher earnings and an improved pre‑tax operating margin in Q2 2026. This points to operational strength even amid flow headwinds.